600267: Zhejiang Hisun Pharmaceutical Co.Ltd(600267) announcement on completing the filing of private investment funds for the investment funds involved in the establishment

Stock abbreviation: Zhejiang Hisun Pharmaceutical Co.Ltd(600267) Stock Code: 600267 Announcement No.: Lin 2022-06 bond abbreviation: Haizheng fixed transfer bond Code: 110813

Zhejiang Hisun Pharmaceutical Co.Ltd(600267)

Announcement on the completion of the filing of private investment funds by the investment funds participating in the establishment

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.

On November 16, 2021, the 35th meeting of the eighth board of directors of Zhejiang Hisun Pharmaceutical Co.Ltd(600267) (hereinafter referred to as “the company”) deliberated and adopted the proposal on participating in investment in Taizhou Jiaojiang Yingfei Haizheng income generating investment partnership (limited partnership), and agreed that the company and its wholly-owned subsidiary Zhejiang Haizheng investment Management Co., Ltd., Taizhou Yingfei income generating Venture Capital Co., Ltd Yingfeinidi No. 2 (Zhuhai) venture capital partnership (limited partnership), Taizhou Asset Management Co., Ltd Taizhou Bay Kechuang Valley Investment Co., Ltd. jointly invests in Taizhou Jiaojiang yingfeihaizheng income generating investment partnership (limited partnership) led by yingfeinidi (Zhuhai) Venture Capital Management Co., Ltd. (the name is tentative, and the name approved by the industrial and commercial department shall prevail). For details, please refer to China Securities Journal, Shanghai Securities News, securities times and the website of Shanghai Stock Exchange (www.sse. Com. CN.) on November 17, 2021 The Zhejiang Hisun Pharmaceutical Co.Ltd(600267) announcement on investment in partnership enterprises and related party transactions disclosed (Announcement No.: Lin 2021-115). Recently, the company received a notice from the fund manager yingfeinidi (Zhuhai) Venture Capital Management Co., Ltd. that yingfeihaizheng income generating venture capital partnership (limited partnership) in Jiaojiang, Taizhou has completed the filing procedures of private investment fund in China Securities Investment Fund Industry Association and obtained the Filing Certificate of private investment fund. The filing information is as follows:

Fund Name: Taizhou Jiaojiang yingfeihaizheng income generating venture capital partnership (limited partnership)

Name of manager: Infiniti (Zhuhai) Venture Capital Management Co., Ltd

Name of custodian: Agricultural Bank Of China Limited(601288)

Filing Code: stq083

It is hereby announced.

Zhejiang Hisun Pharmaceutical Co.Ltd(600267) board of directors January 20, 2002

- Advertisment -